Canadian Blood and Marrow Transplant Group
Cure Stems From Here
About Us
Clinical Trials Network
General Information
Blood and marrow transplantation (BMT) is playing an increasing role in the management of patients with otherwise fatal diseases of the hematopoietic and immune system and solid tumours. Currently, over 1200 transplants are performed annually by 23 Canadian programs, with the number of transplants and transplant centres growing every year. New technologies and management strategies for improving the success of BMT are emerging rapidly from academic centres and industry; their expeditious testing, timely dissemination of results and subsequent implementation are mandatory to ensure the best care and risk management for Canadians in need of a transplant.
While Canada's healthcare system offers a uniquely favourable environment for testing new therapies, relatively few large and decisive Canadian trials have been completed. While large-scale studies demand resources and patient participants very often beyond that which is available in a single Canadian centre, a network of cooperating centres would allow Canadians to conduct large and decisive studies in a timely manner. To this end, the CBMTG has established the Clinical Trials Network (CBMTG-CTN).
About Us
The mission of the CBMTG-CTN is to improve the safety, availability, and efficacy of hematopoietic stem cell transplantation for adults and children in Canada and to perform clinical research trials that will define optimal hematopoietic stem cell transplantation for adults and children. In addition, we strive to conduct laboratory research that will translate into more effective treatments with reduced short and long-term side effects and to
build partnerships that will help fulfill the mission of the Canadian
Blood and Marrow Transplant Group and improve the health of adults and
children throughout the world.
Chaired by Dr. Ronan Foley, the
CBMTG-CTN governs the overall
activities of the committee, including reviewing
and approving the research agenda, formulating and monitoring policies
and procedures, guiding research activities and overseeing
communications within the CTN and with the greater scientific community
and public. Research concept proposals are solicited, developed and
managed by the CTN.
Membership List
Chair: Dr. Ronan Foley
Members: Dr. Harry Atkins, Dr. Karen Ballen, Dr. Christopher Bredeson, Dr. Rena Buckstein, Dr. Guy Cantin, Dr. Martin Champagne, Dr. Steven Couban, Dr. Jeffrey Davis, Tammy Degelder, Dr. John Doyle, Dr. Michael Duval, Dr. Christian Fibich, Dr. Ahmed Galal, Dr. Vikas Gupta, Dr. Wanda Hasagawa, Dr. Kang Howson-Jan, Dr. Lothar Heubsch, Dr. Jeff Lipton, Dr. Pedro Lopez, Holly Kerr, Dr. Thomas Kiss, Dr. John Kuruvilla, Dr. David Mitchell, Dr. Jean Roy, Dr. James Russell, Dr. Brenda Sabo, Dr. Marlis, Schroeder, Dr. Kirk Schultz, Dr. Matthew Seftel, Dr. Cindy Toze, Dr. Michael Voralia, Dr. Irwin Walker, Dr. Donna Wall.
Resources (Members Only)
CTN Meeting Agenda - February 19, 2011
Quarterly Reports
List of Publications
Open Studies
Closed Studies
0601 Protocol
For more information about CBMTG Clinical Trials Open Studies, Concept Proposals or the CBMTG Clinical Trials Network, please contact Dr. Ronan Foley at foleyr@hhsc.ca or the CBMTG Head Office at cbmtg@malachite-mgmt.com.
CTN In-person Meeting at ASBMT
Saturday, February 4, 2012, from 1:30-5pm
Manchester Grand Hyatt San Diego, Madeline A Meeting Room
Please RSVP to sharon.leung@malachite-mgmt.com by January 25, 2012
